Hims Hers Health News - June 17, 2026
Hims & Hers Eyes 34% Upside, Driven by GLP-1 Growth
Barclays raised its price target for Hims & Hers Health (NYSE: HIMS) to $39 from $29. This adjustment represents a potential upside of more than 34%. The bank...
🟢 Hims Hers Health Inc extends move to 5.1% up
HIMS is trading at $33.08, up 5.1% versus the comparison close of $31.47 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 Hims Hers Health Inc is trading 4.1% up today as weight-loss growth expectations fuel multi-day rally
Hims Hers Health Inc is trading 4.1% up now at $32.75 as investors extend a sharp multi-day rally following bullish growth expectations in new weight-loss...
Hims & Hers jumps 12%, eyeing $19 billion peptide market expansion
Hims & Hers Health (HIMS) shares surged over 12% on Monday. This rally marks the stock's strongest single-day performance in two months. Investor optimism...